Let’s look at the key reasons that are pushing Aquestive Therapeutics Inc (AQST) to new highs

On Monday, Aquestive Therapeutics Inc (NASDAQ: AQST) opened higher 4.50% from the last session, before settling in for the closing price of $4.44. Price fluctuations for AQST have ranged from $1.61 to $6.23 over the past 52 weeks.

Healthcare Sector giant saw their annual sales slid by -4.81% over the last five years. Company’s average yearly earnings per share was noted -234.62% at the time writing. With a float of $77.55 million, this company’s outstanding shares have now reached $91.18 million.

The firm has a total of 135 workers. Let’s measure their productivity. In terms of profitability, gross margin is 69.39%, operating margin of -35.83%, and the pretax margin is -59.58%.

Aquestive Therapeutics Inc (AQST) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Aquestive Therapeutics Inc is 14.94%, while institutional ownership is 42.26%. The most recent insider transaction that took place on Mar 15 ’24, was worth 300,000. In this transaction Chief Innovation/Tech Officer of this company sold 50,000 shares at a rate of $6.00, taking the stock ownership to the 984,476 shares. Before that another transaction happened on Mar 08 ’24, when Company’s Chief Innovation/Tech Officer sold 25,000 for $5.19, making the entire transaction worth $129,685. This insider now owns 1,040,371 shares in total.

Aquestive Therapeutics Inc (AQST) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -234.62% per share during the next fiscal year.

Aquestive Therapeutics Inc (NASDAQ: AQST) Trading Performance Indicators

Check out the current performance indicators for Aquestive Therapeutics Inc (AQST). In the past quarter, the stock posted a quick ratio of 5.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.98.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.56 in one year’s time.

Technical Analysis of Aquestive Therapeutics Inc (AQST)

Analysing the last 5-days average volume posted by the [Aquestive Therapeutics Inc, AQST], we can find that recorded value of 1.56 million was lower than the volume posted last year of 1.75 million. As of the previous 9 days, the stock’s Stochastic %D was 10.27%. Additionally, its Average True Range was 0.34.

During the past 100 days, Aquestive Therapeutics Inc’s (AQST) raw stochastic average was set at 66.47%, which indicates a significant increase from 19.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 74.27% in the past 14 days, which was higher than the 72.14% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.99, while its 200-day Moving Average is $3.91. Now, the first resistance to watch is $4.74. This is followed by the second major resistance level at $4.85. The third major resistance level sits at $5.04. If the price goes on to break the first support level at $4.45, it is likely to go to the next support level at $4.26. Now, if the price goes above the second support level, the third support stands at $4.15.

Aquestive Therapeutics Inc (NASDAQ: AQST) Key Stats

There are currently 91,178K shares outstanding in the company with a market cap of 411.03 million. Presently, the company’s annual sales total 50,580 K according to its annual income of -7,870 K. Last quarter, the company’s sales amounted to 13,540 K and its income totaled -11,510 K.